Applied Therapeutics Inc (NASDAQ: APLT): How It Has Performed & Trended

In the last trading session, 1.96 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 1.95. Most recently the company’s share price was $0.43, and it changed around -$0.03 or -5.54% from the last close, which brings the market valuation of the company to $61.57M. APLT currently trades at a discount to its 52-week high of $10.62, offering almost -2369.77% off that amount. The share price’s 52-week low was $0.29, which indicates that the current value has risen by an impressive 32.56% since then.

Applied Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended APLT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.

Applied Therapeutics Inc (NASDAQ:APLT) trade information

Instantly APLT has showed a red trend with a performance of -5.54% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4940 on recent trading dayincreased the stock’s daily price by 12.96%. The company’s shares are currently down -49.21% year-to-date, but still up 11.00% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is 6.05% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $4.5, which translates to bulls needing to increase their stock price by 90.44% from its current value. Analyst projections state that APLT is forecast to be at a low of $4 and a high of $5.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 26.57%. Applied Therapeutics Inc earnings are expected to increase by 9.39% in 2025, but the outlook is positive 25.05% per year for the next five years.

APLT Dividends

Applied Therapeutics Inc’s next quarterly earnings report is expected to be released in June.

Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 5.32% of Applied Therapeutics Inc shares, and 88.67% of them are in the hands of institutional investors. The stock currently has a share float of 93.65%. Applied Therapeutics Inc stock is held by 159.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 70.7533% of the shares, which is about 10.21 million shares worth $47.69 million.

VR ADVISER, LLC, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price Small-Cap Value Fund, Inc. were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.1 shares worth $1.35 million, making up 2.19% of all outstanding shares. On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. held roughly 3.04 shares worth around $1.32 million, which represents about 2.15% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.